Current clinical trials testing the combination of immunotherapy with radiotherapy.
about
DNA exonuclease Trex1 regulates radiotherapy-induced tumour immunogenicity.Immunotherapy Combined with Large Fractions of Radiotherapy: Stereotactic Radiosurgery for Brain Metastases-Implications for Intraoperative Radiotherapy after Resection.Towards precision radiotherapy for use with immune checkpoint blockers.The future of immune checkpoint cancer therapy after PD-1 and CTLA-4.Checkpoint inhibitors in advanced melanoma: effect on the field of immunotherapy.Combining radiotherapy with immunotherapy: the past, the present and the future.A perspective on the impact of radiation therapy on the immune rheostat.Preclinical rationale for combining radiation therapy and immunotherapy beyond checkpoint inhibitors (i.e., CART).Molecular Pathways: Oncologic Pathways and Their Role in T-cell Exclusion and Immune Evasion-A New Role for the AXL Receptor Tyrosine Kinase.Previous radiotherapy and the clinical activity and toxicity of pembrolizumab in the treatment of non-small-cell lung cancer: a secondary analysis of the KEYNOTE-001 phase 1 trial.Targeting the PD-1 pathway in pediatric solid tumors and brain tumors.Capecitabine in locally advanced anal cancer, do we need randomised evidence?Barriers to Radiation-Induced In Situ Tumor Vaccination.DNA Damage and Repair Biomarkers of Immunotherapy Response.Exploiting poly(I:C) to induce cancer cell apoptosis.High dose-rate Intra-Operative Radiation Therapy During High Risk Genitourinary Surgery: Initial Observations and a Proposal for its Study in Bladder Cancer.Improving radiotherapy in cancer treatment: Promises and challenges.cGAS-STING Activation in the Tumor Microenvironment and Its Role in Cancer Immunity.Long non-coding RNAs associated with non-small cell lung cancer.Abscopal effect in recurrent colorectal cancer treated with carbon-ion radiation therapy: 2 case reports.Future perspectives in melanoma research "Melanoma Bridge", Napoli, November 30th-3rd December 2016.Peripheral and local predictive immune signatures identified in a phase II trial of ipilimumab with carboplatin/paclitaxel in unresectable stage III or stage IV melanoma.Toll-like receptor expression in human non-small cell lung carcinoma: potential prognostic indicators of disease.Radiotherapy and CTLA-4 Blockade Shape the TCR Repertoire of Tumor-Infiltrating T Cells.Can radiotherapy potentiate the effectiveness of immune checkpoint inhibitors in lung cancer?Personalized ex vivo multiple peptide enrichment and detection of T cells reactive to multiple tumor-associated antigens in prostate cancer patients.Immune recognition of irradiated cancer cells.Nanotechnologies in Pancreatic Cancer Therapy.Immunotherapeutics for the treatment of prostate cancer: a patent landscape based on key therapeutic mechanisms of actions.Using immunotherapy to boost the abscopal effect.Improving immune-vascular crosstalk for cancer immunotherapy.Radiation therapy and immunotherapy: what is the optimal timing or sequencing?Dying to Be Noticed: Epigenetic Regulation of Immunogenic Cell Death for Cancer Immunotherapy.Radiotherapy-induced anti-tumor immune response and immune-related adverse events in a case of recurrent nasopharyngeal carcinoma undergoing anti-PD-1 immunotherapy.Priming the Abscopal Effect Using Multifunctional Smart Radiotherapy Biomaterials Loaded with Immunoadjuvants.Emerging biomarkers for the combination of radiotherapy and immune checkpoint blockers.Immunotherapy for Head and Neck Squamous Cell Carcinoma.The Impact of Radiation on the Tumor Microenvironment: Effect of Dose and Fractionation Schedules.Sites of recurrent disease and prognostic factors in SCLC patients treated with radiochemotherapy.Stereotactic Body Radiation Therapy in the Management of Upper GI Malignancies.
P2860
Q33804663-6D656D3F-7C69-4372-A3B5-08B92CEF3AFCQ38632924-0BB374F3-8971-434F-83C6-FD33FA1C9C30Q38656599-12C8A164-9E20-4785-B13E-DCF8208A76CAQ38666253-F94C3A70-901D-4CC3-8A7C-79BA79F41FA6Q38672084-25B4E607-42F1-46FC-994B-33F5148F91CCQ38679418-E54F3CE6-923C-4D39-8CC1-4AFF901D9DBFQ38679488-F0A65B9C-9F9E-4FE0-B737-1BB69A60F09DQ38681083-5E3CEF9A-C196-4E18-9D1A-489C62F4BB26Q38746437-DEC1AF56-89E5-43B2-81BE-8BDBE75FFE28Q38760078-3FC4A0E4-F057-4BCD-BDFD-F456FCB109D3Q38819982-0965B167-74FD-44D2-BBB5-8D6A0556FABCQ39170865-9845785D-85CF-4BA7-912F-915A376F6C9DQ39203685-4E29DB01-F64D-4016-89AE-2E5CBF6BEC6DQ39384263-CA183461-8524-4775-BD13-7CA1D1BA1D09Q40062585-41534BE3-7CC6-4672-9583-B81FE56C5DF8Q40086164-7E6236FC-7EBC-4A79-A25C-2EB18CDAC2EFQ41899048-DF04FA78-4686-4940-9E9D-7B6BB4EA1CBEQ41997059-BF9B5AFA-BBF8-4E04-B911-3AFF3E000B3CQ42366666-75D641B0-9C41-4BE2-936E-2D01EBA2FC9EQ43379642-34A96F8D-5504-441D-B866-CFFE37D57917Q46721978-FE2ADCA3-2560-4551-B1BA-AAB130D1330EQ46865924-BC9BCBFD-F12F-40B9-9EF3-91672E91CEB0Q47100766-CA702D47-B981-494A-A477-EA7B9477D054Q47405972-E24CE1EC-A760-4C88-861C-F5BCC7191955Q47821832-624C14F2-B33D-4312-85C7-B2B4CAED96FCQ48135793-537B1AF3-E7C9-4BEC-A8B7-57C7E3664BE1Q48193633-1527944D-D4E7-4C0A-82B5-1EB7DA810D3DQ48293480-35B19540-E879-42E3-B05D-FB3BBFAAEF22Q49951814-37761788-A26C-453C-90FD-BD9813C59039Q49958115-5039D624-79BE-4605-B94C-A2275885D64AQ50051034-4B60D71F-9E73-4FB3-B3A9-CD55415ED569Q50109474-4173792E-1924-4532-8A17-073362C94D5DQ52581847-BA2ECEDC-3950-43F7-A6B8-4959E73067BFQ52602002-C9E661AE-FC9A-4D5C-A4F3-8FBB4CA3E033Q52723401-26F365F7-111C-4C41-BAC9-C6B92F04C67DQ52743918-1A293FEE-4FCD-497A-A204-FF886B9DADE6Q53704789-CC57B478-79E2-45C7-B10F-24731A596878Q54942438-8AF4C23A-EC20-4295-A4EA-9DB5D55B2EDEQ55023905-D3C45A94-83CF-4CCC-A089-9D5CBE20E6C0Q55162030-11393962-7B33-47A3-833B-E2B60580ED87
P2860
Current clinical trials testing the combination of immunotherapy with radiotherapy.
description
2016 nî lūn-bûn
@nan
2016 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Current clinical trials testing the combination of immunotherapy with radiotherapy.
@ast
Current clinical trials testing the combination of immunotherapy with radiotherapy.
@en
type
label
Current clinical trials testing the combination of immunotherapy with radiotherapy.
@ast
Current clinical trials testing the combination of immunotherapy with radiotherapy.
@en
prefLabel
Current clinical trials testing the combination of immunotherapy with radiotherapy.
@ast
Current clinical trials testing the combination of immunotherapy with radiotherapy.
@en
P2860
P1476
Current clinical trials testing the combination of immunotherapy with radiotherapy
@en
P2093
Josephine Kang
Silvia Formenti
P2860
P2888
P356
10.1186/S40425-016-0156-7
P577
2016-09-20T00:00:00Z
P6179
1011176694